Literature DB >> 23217877

The prognostic significance of blastemal predominant histology in initially resected Wilms' tumors: a report from the Study Group for Pediatric Solid Tumors in the Kyushu Area, Japan.

Yoshiaki Kinoshita1, Aiko Suminoe, Hiroko Inada, Minoru Yagi, Fumio Yanai, Yoshio Zaizen, Masanori Nishi, Yukihiro Inomata, Kiyoshi Kawakami, Hiroshi Matsufuji, Souichi Suenobu, Noritoshi Handa, Kenichi Kohashi, Yoshinao Oda, Toshiro Hara, Tomoaki Taguchi.   

Abstract

BACKGROUND AND
PURPOSE: The strategy used to treat pediatric renal tumors in Japan is based on the Japanese Wilms' Tumor Study (JWiTS) protocol, which was based on the National Wilms' Tumor Study (NWTS)-5 regimen. The regimen is characterized by an initial radical operation, followed by adjuvant chemotherapy and radiotherapy. Concerning the histological classification, a new classification based on the International Society of Pediatric Oncology (SIOP) classification was used beginning in 2008. The main points of revision are that the "blastemal predominant type" was classified as an independent category in the Wilms' tumor subtypes. The purpose of this study was to analyze the biological characteristics from the standpoint of the newly established histological classification.
MATERIALS AND METHODS: From 1971 to 2005, 174 cases of Wilms' tumors treated with an initial operation followed by adjuvant therapy were re-evaluated by the new histological classification. Histologically, all these materials showed no secondary changes associated with adjuvant therapy.
RESULTS: According to the new classification, Wilms' tumors were classified into four subtypes, including the mixed type (n=112), epithelial type (n=17), mesenchymal type (n=15), and blastemal predominant type (n=26). The 5 year overall survival rates were as follows; mixed type (90.1%), epithelial type (100%), mesenchymal type (93.3%), and blastemal predominant type (65.4%).
CONCLUSION: The patients with blastemal predominant tumors demonstrated a significantly worse prognosis compared with those of other subtypes. The treatment strategy of blastemal predominant category should be distinguished from the other favorable subtypes.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23217877     DOI: 10.1016/j.jpedsurg.2012.09.009

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  5 in total

1.  Glypican-3 mRNA expression level in Wilms tumor: correlation with histological type, stage, and outcome.

Authors:  Md Nahidul Wari; Archana George Vallonthaiel; Aijaz Ahmed; Deepali Saxena; Venkateswaran K Iyer; Sandeep R Mathur; Sandeep Agarwala; Sameer Bakhshi; V Srinivas; P Chattopadhyaya; Arundhati Sharma; S Datta Gupta; Amit Dinda
Journal:  Pediatr Surg Int       Date:  2017-04-21       Impact factor: 1.827

2.  New risk classification is necessary in the treatment of Wilms tumor.

Authors:  Takaharu Oue
Journal:  Transl Pediatr       Date:  2014-01

3.  Intra- and interobserver variability of whole-tumour apparent diffusion coefficient measurements in nephroblastoma: a pilot study.

Authors:  Annemieke S Littooij; Paul D Humphries; Øystein E Olsen
Journal:  Pediatr Radiol       Date:  2015-05-08

4.  SIX2 Effects on Wilms Tumor Biology.

Authors:  Janene Pierce; Andrew J Murphy; Alexis Panzer; Christian de Caestecker; Gregory D Ayers; David Neblett; Kenyi Saito-Diaz; Mark de Caestecker; Harold N Lovvorn
Journal:  Transl Oncol       Date:  2014-12       Impact factor: 4.243

5.  A rare occurrence of neonatal nephroblastoma in sub-saharan Africa: a case report and management in a resource-constrained region.

Authors:  Féfé Khuabi Matondo; Aléine Nzazi Budiongo; Bruno Muyala Tady; Bienvenu Massamba Lebwaze; Michel Tshikwela Lelo; Jean Lambert Gini-Ehungu; Idesbald Mwepu; Emmanuel Dimbu Nkidiaka; Michel Ntetani Aloni
Journal:  Rare Tumors       Date:  2015-03-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.